Yep, they’ve approved another one for newborns. This one for RSV. And it’s got an over 11% adverse reaction rate.
FDA Greenlights Merck’s RSV Shot for Newborns — Clinical Trials Showed 11.71% Rate of Serious Adverse Events, Including Death
The clinical trial results posted on the government website http://ClinicalTrials.gov included serious neurological adverse reactions that Dr. Peter Selley, a U.K. general practitioner who has closely followed the development of the drugs for RSV, called “concerning.”
These included febrile convulsions, seizures, facial paralysis and brain injury at about three times the rate in the vaccine group (25 of 2,409) as the placebo group (4 of 1,202).
Children’s Health Defense Senior Research Scientist Karl Jablonowski said the trials showed a serious adverse event rate of 11.71% and included:
👉 A 50% greater chance of death (three deaths in the group that received the shot versus one in the placebo group).
👉 A 350% greater chance of an upper respiratory tract infection.
👉 A 63% greater chance of a lower respiratory tract infection.
👉 A 41% greater chance of febrile convulsion.
Fortunately the next step is the Advisory Committee on Immunization Practices (ACIP) which has just been reconstituted by RFK Jr. The previous rubber-stamping group was entirely appointed by the Biden administration.
“A clean sweep is necessary to reestablish public confidence in vaccine science,” Kennedy concluded. “ACIP’s new members will prioritize public health and evidence-based medicine. The Committee will no longer function as a rubber stamp for industry profit-taking agendas. The entire world once looked to American health regulators for guidance, inspiration, scientific impartiality, and unimpeachable integrity. Public trust has eroded. Only through radical transparency and gold standard science, will we earn it back.”
They’re the only ones who stand between the FDA’s ludicrous ‘approvals’ and damage and death to babies and children.
Leave a Reply